Medicaid expands home care access while imposing pharmacy compliance costs
S. 891 — Bipartisan Health Care Act · Filed by Ron Wyden (D-OR) · 1 cosponsor · Introduced Mar 6, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill makes multiple changes to Medicaid and CHIP programs, primarily focused on expanding home and community-based services (HCBS) for eligible individuals, improving data transparency on waiting lists and service delivery, and strengthening oversight of pharmacy pricing and provider screening. Key provisions include: a demonstration program allowing up to 5 states to expand HCBS coverage with federal planning grants; removal of age restrictions for working adults with disabilities; protections for military families relocating; requirements for states to verify address information and screen for deceased providers; studies on maternity care costs; and new rules requiring transparent pharmacy pricing to prevent markup abuses.
Why we flagged it
The bill's core function is to expand Medicaid HCBS access through a demonstration program, remove age caps for working disabled adults, and impose new transparency and compliance requirements on pharmacies and states. While framed as 'bipartisan health care,' the substance is primarily regulatory expansion and data-collection mandates.
What the text implies
- The demonstration program's selection criteria (geographic diversity, rural preference, mental health inclusion) may create unequal access across states, with some populations benefiting while others remain on waiting lists.
- New pharmacy survey and penalty provisions (up to $100,000 per violation) may reduce participation by small and rural pharmacies, potentially worsening access in underserved areas despite stated transparency goals.
The full analysis lists 5 implications of this text.
Who stands to gain
home and community-based services providers; specialty pharmacies and mail-order pharmacies (initially exempt from survey requirements); hospitals with high Medicaid/CHIP patient populations (DSH allotment extensions)